These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 32615995

  • 1. Angiotensin II receptor 1 antibodies associate with post-transplant focal segmental glomerulosclerosis and proteinuria.
    Abuzeineh M, Aala A, Alasfar S, Alachkar N.
    BMC Nephrol; 2020 Jul 02; 21(1):253. PubMed ID: 32615995
    [Abstract] [Full Text] [Related]

  • 2. Pre-transplant angiotensin receptor II type 1 antibodies and risk of post-transplant focal segmental glomerulosclerosis recurrence.
    Mujtaba MA, Sharfuddin AA, Book BL, Goggins WC, Khalil AA, Mishler DP, Fridell JA, Yaqub MS, Taber TE.
    Clin Transplant; 2015 Jul 02; 29(7):606-11. PubMed ID: 25973696
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome.
    El Band JEK, Llorente S, Martinez-Garcia P, Alfaro R, Jimenez-Coll V, Boix F, Galián JA, Martinez-Banaclocha H, Botella C, Moya-Quiles MR, Minguela A, Legaz I, Muro M.
    Curr Protein Pept Sci; 2021 Jul 02; 22(10):745-757. PubMed ID: 34967284
    [Abstract] [Full Text] [Related]

  • 4. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes.
    Banasik M, Boratyńska M, Kościelska-Kasprzak K, Kamińska D, Bartoszek D, Zabińska M, Myszka M, Zmonarski S, Protasiewicz M, Nowakowska B, Hałoń A, Chudoba P, Klinger M.
    Transpl Int; 2014 Oct 02; 27(10):1029-38. PubMed ID: 24909812
    [Abstract] [Full Text] [Related]

  • 5. Pre-transplant Screening for Non-HLA Antibodies: Who should be Tested?
    Philogene MC, Zhou S, Lonze BE, Bagnasco S, Alasfar S, Montgomery RA, Kraus E, Jackson AM, Leffell MS, Zachary AA.
    Hum Immunol; 2018 Apr 02; 79(4):195-202. PubMed ID: 29428484
    [Abstract] [Full Text] [Related]

  • 6. Focal Segmental Glomerulosclerosis Superimposed on Transplant Glomerulopathy: Implications for Graft Survival.
    Zhu Y, Fan Y, Xu F, Liang S, Liang D, Li P, Xia Y, Zhu X, Yang F, Chen J, Zeng C.
    Am J Nephrol; 2021 Apr 02; 52(10-11):788-797. PubMed ID: 34749369
    [Abstract] [Full Text] [Related]

  • 7. Pediatric focal segmental glomerulosclerosis: favorable transplantation outcome with plasma exchange.
    Fadel FI, Bazaraa HM, Abdel Mawla MA, Salah DM.
    Ital J Pediatr; 2021 Dec 14; 47(1):236. PubMed ID: 34906202
    [Abstract] [Full Text] [Related]

  • 8. Management of proteinuria in the transplanted patient.
    Seeman T.
    Pediatr Nephrol; 2015 Jun 14; 30(6):889-903. PubMed ID: 25159718
    [Abstract] [Full Text] [Related]

  • 9. Mortality and Allograft Loss Trends Among US Pediatric Kidney Transplant Recipients With and Without Focal Segmental Glomerulosclerosis.
    Wang CS, Gander J, Patzer RE, Greenbaum LA.
    Am J Kidney Dis; 2018 Mar 14; 71(3):392-398. PubMed ID: 29277509
    [Abstract] [Full Text] [Related]

  • 10. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
    Lefaucheur C, Viglietti D, Bouatou Y, Philippe A, Pievani D, Aubert O, Duong Van Huyen JP, Taupin JL, Glotz D, Legendre C, Loupy A, Halloran PF, Dragun D.
    Kidney Int; 2019 Jul 14; 96(1):189-201. PubMed ID: 31005275
    [Abstract] [Full Text] [Related]

  • 11. Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab.
    Alachkar N, Li J, Matar D, Vujjini V, Alasfar S, Tracy M, Reiser J, Wei C.
    BMC Nephrol; 2018 Dec 17; 19(1):361. PubMed ID: 30558559
    [Abstract] [Full Text] [Related]

  • 12. Effect of angiotensin II type 1 receptor antibodies on graft function and survival in paediatric kidney transplant recipients.
    Kermond RF, Kim S, Mackie F, Hahn D, Carroll RP, Sharma A, Durkan AM.
    HLA; 2024 Sep 17; 104(3):e15649. PubMed ID: 39247998
    [Abstract] [Full Text] [Related]

  • 13. Long-Term Outcomes of Kidney Transplant Recipients With Primary Idiopathic Focal Segmental Glomerulosclerosis.
    Staeck O, Halleck F, Budde K, Khadzhynov D.
    Transplant Proc; 2017 Dec 17; 49(10):2256-2259. PubMed ID: 29198656
    [Abstract] [Full Text] [Related]

  • 14. Long-Term Outcome of Kidney Transplantation in Recipients with Focal Segmental Glomerulosclerosis.
    Francis A, Trnka P, McTaggart SJ.
    Clin J Am Soc Nephrol; 2016 Nov 07; 11(11):2041-2046. PubMed ID: 27797890
    [Abstract] [Full Text] [Related]

  • 15. Focal and segmental glomerulosclerosis in renal allograft recipients: a clinico-pathologic study of 37 cases.
    Gupta R, Sharma A, Mahanta PJ, Agarwal SK, Dinda AK.
    Saudi J Kidney Dis Transpl; 2013 Jan 07; 24(1):8-14. PubMed ID: 23354185
    [Abstract] [Full Text] [Related]

  • 16. Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients.
    Gohh RY, Yango AF, Morrissey PE, Monaco AP, Gautam A, Sharma M, McCarthy ET, Savin VJ.
    Am J Transplant; 2005 Dec 07; 5(12):2907-12. PubMed ID: 16303004
    [Abstract] [Full Text] [Related]

  • 17. Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience.
    Hubsch H, Montané B, Abitbol C, Chandar J, Shariatmadar S, Ciancio G, Burke G, Miller J, Strauss J, Zilleruelo G.
    Pediatr Nephrol; 2005 Feb 07; 20(2):210-6. PubMed ID: 15605284
    [Abstract] [Full Text] [Related]

  • 18. Early use of plasmapheresis for recurrent post-transplant FSGS.
    Pradhan M, Petro J, Palmer J, Meyers K, Baluarte HJ.
    Pediatr Nephrol; 2003 Sep 07; 18(9):934-8. PubMed ID: 12836097
    [Abstract] [Full Text] [Related]

  • 19. Presentation and Outcomes of Antibody-Mediated Rejection Associated With Angiotensin II Receptor 1 Antibodies Among Kidney Transplant Recipients.
    Abuzeineh M, Kyeso Y, Philogene MC, Alachkar N, Alasfar S.
    Transplant Proc; 2021 Jun 07; 53(5):1501-1508. PubMed ID: 33573814
    [Abstract] [Full Text] [Related]

  • 20. Accelerated rejection, thrombosis, and graft failure with angiotensin II type 1 receptor antibodies.
    Pearl MH, Leuchter RK, Reed EF, Zhang Q, Ettenger RB, Tsai EW.
    Pediatr Nephrol; 2015 Aug 07; 30(8):1371-4. PubMed ID: 25956702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.